NCT06538493 Jumpstarting Advance Care Planning With ANAI People
| NCT ID | NCT06538493 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Southcentral Foundation |
| Condition | Advance Care Planning |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2025-04-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The older Alaska Native/American Indian (ANAI) population is increasing at twice the rate of the general population with a higher burden of serious illness. Older ANAI adults with serious illness are half as likely to have advance directives (AD), indicating a need for improved access to and utilization of advance care planning (ACP) to ensure that medical care aligns with the values, goals, and preferences of ANAI patients and their families throughout the illness trajectory. The major goals of this cluster randomized trial (CRT) are to (1) evaluate the comparative effectiveness of usual care and JUMPSTART- ANAI, a culturally tailored ACP communication intervention, for prompting patient-driven ACP conversations between ANAI adults and primary care providers and to (1) identify key factors to successfully implement the intervention in health systems serving ANAI adults with serious illness.
Eligibility Criteria
Inclusion Criteria: Age 40 or older with a qualifying serious illness condition (e.g., COPD) OR Age 65 or older (regardless of diagnosis) AND Alaska Native and/or American Indian AND Empaneled to a primary care provider AND 2 or more to primary care in last 12 months AND No advance directives documented in electronic health record Exclusion Criteria: Unable to provide informed consent AND/OR Not able to complete 30-minute study visit by phone, video call, or in person
Contact & Investigator
Jennifer Shaw, PhD
PRINCIPAL INVESTIGATOR
University of Alaska Fairbanks
Frequently Asked Questions
Who can join the NCT06538493 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Advance Care Planning. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06538493 currently recruiting?
Yes, NCT06538493 is actively recruiting participants. Contact the research team at smedlock@scf.cc for enrollment information.
Where is the NCT06538493 trial being conducted?
This trial is being conducted at Anchorage, United States.
Who is sponsoring the NCT06538493 clinical trial?
NCT06538493 is sponsored by Southcentral Foundation. The principal investigator is Jennifer Shaw, PhD at University of Alaska Fairbanks. The trial plans to enroll 400 participants.